Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299K Buy
2,330
+2
+0.1% +$234 0.08% 141
2026
Q1
$280K Sell
2,328
-66
-3% -$7.62K 0.08% 141
2025
Q4
$252K Buy
+2,394
New +$225K 0.08% 148
2025
Q2
Sell
-2,781
Closed -$250K 163
2025
Q1
$250K Sell
2,781
-1,021
-27% -$95.3K 0.09% 129
2024
Q4
$378K Sell
3,802
-1,495
-28% -$154K 0.14% 106
2024
Q3
$602K Sell
5,297
-181
-3% -$21.5K 0.22% 74
2024
Q2
$678K Buy
+5,478
New +$706K 0.26% 69
2023
Q4
$507K Buy
+4,649
New +$483K 0.23% 71

Other funds holding MRK

Hobbs Group Advisors's MRK Position: Q2 2026 in Review

Hobbs Group Advisors increased its Merck (MRK) stake by 0.09% in Q2 2026, buying an estimated $234 and bringing the position to 2,330 shares worth $299K. The position accounts for 0.08% of the portfolio, ranked #141.

Hobbs Group Advisors first reported a position in MRK in Q4 2023 and has held it in 8 quarters since. The position peaked at $678K in Q2 2024. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hobbs Group Advisors held 2,330 shares of Merck worth $299K as of Q2 2026.
  • Hobbs Group Advisors bought 2 Merck shares in Q2 2026, an estimated $234.
  • Merck made up 0.08% of Hobbs Group Advisors's portfolio in Q2 2026, its #141 holding.
  • Hobbs Group Advisors first reported a position in Merck in Q4 2023 and has held it in 8 quarters since.
  • Hobbs Group Advisors's Merck position peaked at $678K in Q2 2024.
  • 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hobbs Group Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.